Pomelo Care is expanding care beyond pregnancy.
What’s happening: The virtual-first platform secured $92M at a $1.7B valuation to scale preventative, outcomes-driven model into hormonal health and menopause.
Wraparound. Pomelo pairs predictive analytics with 24/7 access to clinical, behavioral, and social support to reduce preterm births, postpartum depression, and NICU admissions while lowering costs.
Partnering with health plans, employers, and Medicaid, it has covered 25M women and children, supporting 7% of all US births.
Follow-up. With new peri- and menopause offerings, Pomelo Care is realigning around women’s healthspan, offering data-driven care journeys that span preconception coaching and virtual doula services to midlife nutrition counseling and HRT.
In a flash. Once narrowly focused on pregnancy, women’s health is entering a new era.
Supported by biometrics and diagnostics, providers are scaling life stage-specific solutions, with WeightWatchers applying GLP-1s, Midi investing in AI for longevity, Maven Clinic syncing with Oura, and Elektra Health partnering with Oscar on menopause insurance.
Punchline: For all the recent breakthroughs, many women still face fragmented care and unanswered questions. Believing small interventions yield big impact, Pomelo and its peers are betting that small, timely interventions can compound into lifelong impact.
